Research on Motives and Performance of Cross-Border M&A-- Case of Mindray Medical's M&A of Hytest
DOI:
https://doi.org/10.54097/8s4nnq51Keywords:
Cross-border M&A; M&A Motivations; Performance of M&A.Abstract
With the acceleration of globalization, cross-border M&A by enterprises have become an important strategic means to achieve resource integration, market expansion, and technological innovation. This paper analyzes the case of Mindray Medical's acquisition of Hytest to explore the motives and performance impact of enterprise cross-border M&A. Firstly, the paper reviews the merger background and clarifies the status of both merging parties. Secondly, the article combines the internal needs of the enterprise and the external environment driving force to point out the main purpose of the merger. Finally, the article shows the merger performance of the enterprise by evaluating its financial and non-financial performance after the merger. The study finds that the M&A combined a variety of key factors and had a positive impact on Mindray Medical in both financial indicators and non-financial aspects. The analysis of this article provides theoretical support and practical inspiration for transnational M&A in other companies.
Downloads
References
[1] Wang Kui, Gao Tianhui, Hu Feng. Analysis of the motives and impact of overseas mergers and acquisitions of Chinese enterprises - comparison with overseas mergers and acquisitions of American enterprises. Asia-Pacific Economy, 2022 (01): 93-101.
[2] Wu Cen, Luo Ting, Rao Pingui. Government guidance, fiscal decentralization and enterprise mergers and acquisitions. Economic Science, 2021 (05)20-36.
[3] Zhang Tianding, Chen Yuying. Determinants of overseas mergers and acquisitions of Chinese enterprises: based on the perspective of global value chain position and incomplete contract. World Economic Research, 2021 (09): 67-80+135.
[4] Guan Huiming, Liu Ligang. Performance evaluation of overseas mergers and acquisitions of Chinese enterprises - overseas mergers and acquisitions cases based on A-share listed companies. Henan Social Science, 2020, (07): 44-52.
[5] Cheng Yao. The wealth effect of mergers and acquisitions and corporate governance. Financial Accounting Monthly, 2020 (20): 39-45.
[6] Zhang Xiaoye, Zhang Yanliang. Performance evaluation and path selection of cross-border mergers and acquisitions of Chinese banks. Investment Research, 2021,40 (07): 110-127.
[7] Zhang Siqiong. The financial risk research of continuous mergers and acquisitions of listed companies in China takes SH Medical as an example. Financial Accounting Learning, 2021 (19):183-185.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Highlights in Business, Economics and Management

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.